Search

Your search keyword '"Sorrentino S"' showing total 753 results
Start Over Author "Sorrentino S"
753 results on '"Sorrentino S"'

1. Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial

Author

Minutolo, Roberto, Simeon, Vittorio, De Nicola, Luca, Chiodini, Paolo, Galiero, Raffaele, Rinaldi, Luca, Caturano, Alfredo, Vetrano, Erica, Sardu, Celestino, Marfella, Raffaele, Sasso, Ferdinando Carlo, Lampitella Jr, A., Lampitella, A., Lanzilli, A., Lascar , N., Masi, S., Mattei, P., Mastrilli, V., Memoli , P., Minutolo, R., Nasti, R., Pagano, A., Pentangelo , M., Pisa, E., Rossi , E., Sasso, F. C, Sorrentino, S., Torella , R., Troise, R., Trucillo, P., Turco, A. A., Turco,, S., Zibella, F., and Zirpoli, L.

Published
2024
Full Text
View/download PDF

2. Counseling in fetal medicine: pre‐ and periviable fetal growth restriction.

Author

Dall'Asta, A., Penas Da Costa, M. A., Sorrentino, S., Lees, C., and Ghi, T.

Subjects
FETAL growth retardation, OBSTETRICS, VERY low birth weight, ABRUPTIO placentae, SMALL for gestational age, HERPES simplex, FETAL macrosomia
Abstract

This article provides information on fetal growth restriction (FGR), a condition where a fetus does not reach its full growth potential due to a pathological factor. It discusses the classification of FGR based on gestational age at diagnosis and explores the causes and outcomes of pre- and periviable FGR. The article emphasizes the importance of genetic counseling and testing in cases of FGR and provides information on the prevalence of genetic anomalies, structural defects, and congenital infections in these cases. It also discusses the incidence and outcome of placental insufficiency as a cause of FGR. The article highlights the varying frequency of hypertensive disorders of pregnancy (HDP) in pre- and periviable FGR and their impact on maternal and fetal/neonatal health. It concludes by discussing the management of pre- and periviable FGR, including the consideration of termination of pregnancy in certain cases and the determination of the mode of delivery for fetuses alive at birth. [Extracted from the article]

Published
2024
Full Text
View/download PDF

4. Measurement of charm production in neutrino charged-current interactions

Author

Kayis-Topaksu, A., Önengüt, G., van Dantzig, R., de Jong, M., Oldeman, R. G. C., Güler, M., Köse, U., Tolun, P., Catanesi, M. G., Muciaccia, M. T., Winter, K., Van de Vyver, B., Vilain, P., Wilquet, G., Saitta, B., Di Capua, E., Ogawa, S., Shibuya, H., Hristova, I. R., Kawamura, T., Kolev, D., Meinhard, H., Panman, J., Rozanov, A., Tsenov, R., Uiterwijk, J. W. E., Zucchelli, P., Goldberg, J., Chikawa, M., Song, J. S., Yoon, C. S., Kodama, K., Ushida, N., Aoki, S., Hara, T., Delbar, T., Favart, D., Grégoire, G., Kalinin, S., Makhlioueva, I., Artamonov, A., Gorbunov, P., Khovansky, V., Shamanov, V., Tsukerman, I., Bruski, N., Frekers, D., Hoshino, K., Kawada, J., Komatsu, M., Miyanishi, M., Nakamura, M., Nakano, T., Narita, K., Niu, K., Niwa, K., Nonaka, N., Sato, O., Toshito, T., Buontempo, S., Cocco, A. G., D'Ambrosio, N., De Lellis, G., De Rosa, G., Di Capua, F., Fiorillo, G., Marotta, A., Messina, M., Migliozzi, P., Lavina, L. Scotto, Strolin, P., Tioukov, V., Okusawa, T., Dore, U., Loverre, P. F., Ludovici, L., Rosa, G., Santacesaria, R., Satta, A., Spada, F. R., Barbuto, E., Bozza, C., Grella, G., Romano, G., Sirignano, C., Sorrentino, S., Sato, Y., and Tezuka, I.

Subjects
High Energy Physics - Experiment
Abstract

The nuclear emulsion target of the CHORUS detector was exposed to the wide-band neutrino beam of the CERN SPS of 27 GeV average neutrino energy from 1994 to 1997. In total about 100000 charged-current neutrino interactions with at least one identified muon were located in the emulsion target and fully reconstructed, using newly developed automated scanning systems. Charmed particles were searched for by a program recognizing particle decays. The observation of the decay in nuclear emulsion makes it possible to select a sample with very low background and minimal kinematical bias. 2013 charged-current interactions with a charmed hadron candidate in the final state were selected and confirmed through visual inspection. The charm production rate induced by neutrinos relative to the charged-current cross-section is measured to be sigma(nu_mu N -> mu- C X)/sigma(CC) = (5.75 +-0.32 stat +-0.30 syst)%. The charm production cross-section as a function of the neutrino energy is also obtained. The results are in good agreement with previous measurements. The charm-quark hadronization produces the following charmed hadrons with relative fractions (in %): f_Dzero = 43.7+-4.5, f_Lambda_c^plus = 19.2+-4.2, f_Dplus = 25.3+-4.2, and f_D_splus = 11.8+-4.7., Comment: 16 pages, 5 figures

Published
2011
Full Text
View/download PDF

6. Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents

Author

Polimeni A., Sorrentino S., Spaccarotella C., Mongiardo A., Sabatino J., De Rosa S., Gori T., Indolfi C., Polimeni, A., Sorrentino, S., Spaccarotella, C., Mongiardo, A., Sabatino, J., De Rosa, S., Gori, T., and Indolfi, C.

Subjects
BMS, BRS, DES, Stent, Thrombosis, Humans, Percutaneous Coronary Intervention, Polymers, Prosthesis Design, Absorbable Implants, Drug-Eluting Stents, Stents, Absorbable Implant, Metals, Thrombosi, Drug-Eluting Stent, Polymer, Human
Abstract

Since their introduction in clinical practice in 1986, different types of coronary stents have been developed and become available for the treatment of coronary artery disease. Stent thrombosis (ST) is an uncommon but harmful complication after percutaneous coronary implantation, with a high occurrence of acute myocardial infarction and risk of mortality. Among several procedural and clinical predictors, the type of coronary stent is a strong determinant of ST. This article reviews the available evidence on the most used coronary stent types in the modern era and the related risk of ST.

Published
2022

9. Cerebral redistribution in late-onset fetal growth restriction: not always the same story (Winner of the SIMP EUBRAIN Award, in memory of J. Claudine Larroche for the study on PVL in 1962)

Author

Dall'Asta, A., primary, Stampalija, T., additional, Prefumo, F., additional, Minopoli, M., additional, Sorrentino, S., additional, Cagninelli, G., additional, Valentini, B., additional, Celora, G.M., additional, Corno, E., additional, Di Pasquo, E., additional, Fichera, A., additional, Ottaviani, C., additional, Fantasia, I., additional, Barbieri, M., additional, Simeone, S., additional, Mecacci, F., additional, and Ghi, T., additional

Published
2023
Full Text
View/download PDF

12. Incidence, clinical features and perinatal outcome in anomalous fetuses with late‐onset growth restriction: cohort study

Author

Dall'Asta, A., primary, Stampalija, T., additional, Mecacci, F., additional, Ramirez Zegarra, R., additional, Sorrentino, S., additional, Minopoli, M., additional, Ottaviani, C., additional, Fantasia, I., additional, Barbieri, M., additional, Lisi, F., additional, Simeone, S., additional, Castellani, R., additional, Fichera, A., additional, Rizzo, G., additional, Prefumo, F., additional, Frusca, T., additional, and Ghi, T., additional

Published
2022
Full Text
View/download PDF

13. Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Author

Guedeney, P, primary, Roule, V, additional, Mesnier, J, additional, Chapelle, C, additional, Portal, J J, additional, Laporte, S, additional, Ollier, E, additional, Zeitouni, M, additional, Kerneis, M, additional, Barthelemy, O, additional, Sorrentino, S, additional, Silvain, J, additional, Vicaut, E, additional, Montalescot, G, additional, and Collet, J P, additional

Published
2022
Full Text
View/download PDF

20. List of contributors

Author

Abe, F., primary, Barnard, P., additional, Blum, R., additional, Chai, G., additional, deBarbadillo, J.J., additional, Di Gianfrancesco, A., additional, Forsberg, U., additional, Fukuda, M., additional, Hald, J., additional, Klöwer, J., additional, Kruger, K.L., additional, Liu, Z., additional, Lucacci, G., additional, Masuyama, F., additional, Roberts, S., additional, Schraven, P., additional, Shingledecker, J.P., additional, Sorrentino, S., additional, Spiegel, M., additional, Xie, X., additional, and Zeiler, G., additional

Published
2017
Full Text
View/download PDF

25. VP38.15: Etiology and outcome in anomalous late onset suspected fetal growth restriction

Author

Dall'Asta, A., primary, Stampalija, T., additional, Mecacci, F., additional, Fantasia, I., additional, Barbieri, M., additional, Fichera, A., additional, Castellani, R., additional, Simeone, S., additional, Maqina, P., additional, Minopoli, M., additional, Sorrentino, S., additional, Cagninelli, G., additional, Rizzo, G., additional, Prefumo, F., additional, Frusca, T., additional, and Ghi, T., additional

Published
2021
Full Text
View/download PDF

26. OC04.10: Incidence and perinatal outcome of late onset fetal growth restriction (FGR) identified within a population of fetuses with suspected FGR diagnosed beyond 32 weeks

Author

Dall'Asta, A., primary, Stampalija, T., additional, Mecacci, F., additional, Schera, G., additional, Fantasia, I., additional, Barbieri, M., additional, Fichera, A., additional, Castellani, R., additional, Simeone, S., additional, Maqina, P., additional, Minopoli, M., additional, Sorrentino, S., additional, Cagninelli, G., additional, Corno, E., additional, Rizzo, G., additional, Prefumo, F., additional, Frusca, T., additional, and Ghi, T., additional

Published
2021
Full Text
View/download PDF

30. Real use of a novel automatic motorized laser balloon for the ablation of atrial fibrillation

Author

Martignani, C, primary, Ziacchi, M, additional, Statuto, G, additional, Bartoli, L, additional, Spadotto, A, additional, Angeletti, A, additional, Massaro, G, additional, Diemberger, I, additional, Sorrentino, S, additional, Capobianco, C, additional, Grassini, D, additional, Ginex, S, additional, Giacopelli, D, additional, Galie, N, additional, and Biffi, M, additional

Published
2021
Full Text
View/download PDF

32. Third-generation laser balloon ablation: rapid mode applicability is associated with shorter time to pulmonary vein isolation

Author

Martignani, C, primary, Ziacchi, M, additional, Statuto, G, additional, Bartoli, L, additional, Spadotto, A, additional, Angeletti, A, additional, Massaro, G, additional, Diemberger, I, additional, Sorrentino, S, additional, Capobianco, C, additional, Giacopelli, D, additional, Bassini, M, additional, Grassini, D, additional, Galie, N, additional, and Biffi, M, additional

Published
2021
Full Text
View/download PDF

33. Efficacy and durability of multifactorial intervention on mortality and MACEs:a randomized clinical trial in type-2 diabetic kidney disease

Author

Sasso, F. C., Pafundi, Pia Clara, Simeon, Vittorio, De Nicola, L., Chiodini, Paolo, Galiero, Raffaele, Rinaldi, Luca, Nevola, Riccardo, Salvatore, Teresa, Sardu, Celestino, Marfella, Raffaele, Adinolfi, Luigi Elio, Minutolo, R., Amelia, U., Acierno, C., Calatola, P., Carbonara, O., Caturano, A., Conte, G., Corigliano, G., Corigliano, M., D’Urso, R., De Matteo, A., De Rosa, N., Del Vecchio, E., Di Giovanni, G., Gatti, A., Gentile, S., Gesuè, L., Improta, L., Lampitella, A., Lanzilli, A., Lascar, N., Masi, S., Mattei, P., Mastrilli, V., Memoli, P., Nasti, R., Pagano, A., Pentangelo, M., Pisa, E., Rossi, E., Sorrentino, S., Torella, R., Troise, R., Trucillo, P., and NID-2 Study Group Investigators

Abstract

Background: Multiple modifiable risk factors for late complications in patients with diabetic kidney disease (DKD), including hyperglycemia, hypertension and dyslipidemia, increase the risk of a poor outcome. DKD is associated with a very high cardiovascular risk, which requires simultaneous treatment of these risk factors by implementing an intensified multifactorial treatment approach. However, the efficacy of a multifactorial intervention on major fatal/non-fatal cardiovascular events (MACEs) in DKD patients has been poorly investigated. Methods: Nephropathy in Diabetes type 2 (NID-2) study is a multicentre, cluster-randomized, open-label clinical trial enrolling 395 DKD patients with albuminuria, diabetic retinopathy (DR) and negative history of CV events in 14 Italian diabetology clinics. Centres were randomly assigned to either Standard-of-Care (SoC) (n = 188) or multifactorial intensive therapy (MT, n = 207) of main cardiovascular risk factors (blood pressure < 130/80 mmHg, glycated haemoglobin < 7%, LDL, HDL and total cholesterol < 100 mg/dL, > 40/50 mg/dL for men/women and < 175 mg/dL, respectively). Primary endpoint was MACEs occurrence by end of follow-up phase. Secondary endpoints included single components of primary endpoint and all-cause death. Results: At the end of intervention period (median 3.84 and 3.40 years in MT and SoC group, respectively), targets achievement was significantly higher in MT. During 13.0 years (IQR 12.4–13.3) of follow-up, 262 MACEs were recorded (116 in MT vs. 146 in SoC). The adjusted Cox shared-frailty model demonstrated 53% lower risk of MACEs in MT arm (adjusted HR 0.47, 95%CI 0.30–0.74, P = 0.001). Similarly, all-cause death risk was 47% lower (adjusted HR 0.53, 95%CI 0.29–0.93, P = 0.027). Conclusion: MT induces a remarkable benefit on the risk of MACEs and mortality in high-risk DKD patients. Clinical Trial Registration ClinicalTrials.gov number, NCT00535925. https://clinicaltrials.gov/ct2/show/NCT00535925

Published
2021

36. Associated charm production in neutrino–nucleus interactions

Author

Kayis-Topaksu, A., Önengüt, G., van Dantzig, R., de Jong, M., Oldeman, R.G.C., Güler, M., Köse, U., Tolun, P., Catanesi, M.G., Muciaccia, M.T., Winter, K., Van de Vyver, B., Vilain, P., Wilquet, G., Saitta, B., Di Capua, E., Ogawa, S., Shibuya, H., Hristova, I.R., Kawamura, T., Kolev, D., Meinhard, H., Panman, J., Rozanov, A., Tsenov, R., Uiterwijk, J.W.E., Zucchelli, P., Goldberg, J., Chikawa, M., Song, J.S., Yoon, C.S., Kodama, K., Ushida, N., Aoki, S., Hara, T., Delbar, T., Favart, D., Grégoire, G., Kalinin, S., Makhlioueva, I., Artamonov, A., Gorbunov, P., Khovansky, V., Shamanov, V., Tsukerman, I., Bruski, N., Frekers, D., Hoshino, K., Kawada, J., Komatsu, M., Miyanishi, M., Nakamura, M., Nakano, T., Narita, K., Niu, K., Niwa, K., Nonaka, N., Sato, O., Toshito, T., Buontempo, S., Cocco, A.G., D’Ambrosio, N., De Lellis, G., De Rosa, G., Di Capua, F., Fiorillo, G., Marotta, A., Migliozzi, P., Scotto Lavina, L., Strolin, P., Tioukov, V., Okusawa, T., Dore, U., Loverre, P.F., Ludovici, L., Rosa, G., Santacesaria, R., Satta, A., Spada, F.R., Barbuto, E., Bozza, C., Grella, G., Romano, G., Sirignano, C., Sorrentino, S., Sato, Y., Tezuka, I., and The CHORUS Collaboration

Published
2007
Full Text
View/download PDF

37. Charged-particle multiplicities in charged-current neutrino– and anti-neutrino–nucleus interactions

Author

Kayis-Topaksu, A., Önengüt, G., van Dantzig, R., de Jong, M., Oldeman, R.G.C., Güler, M., Köse, U., Tolun, P., Catanesi, M.G., Muciaccia, M.T., Winter, K., Van de Vyver, B., Vilain, P., Wilquet, G., Saitta, B., Di Capua, E., Ogawa, S., Shibuya, H., Hristova, I.R., Kawamura, T., Kolev, D., Meinhard, H., Panman, J., Rozanov, A., Tsenov, R., Uiterwijk, J.W.E., Zucchelli, P., Goldberg, J., Chikawa, M., Song, J.S., Yoon, C.S., Kodama, K., Ushida, N., Aoki, S., Hara, T., Delbar, T., Favart, D., Grégoire, G., Kalinin, S., Makhlioueva, I., Artamonov, A., Gorbunov, P., Khovansky, V., Shamanov, V., Tsukerman, I., Bruski, N., Frekers, D., Hoshino, K., Kawada, J., Komatsu, M., Miyanishi, M., Nakamura, M., Nakano, T., Narita, K., Niu, K., Niwa, K., Nonaka, N., Sato, O., Toshito, T., Buontempo, S., Cocco, A.G., D’Ambrosio, N., De Lellis, G., De Rosa, G., Di Capua, F., Fiorillo, G., Marotta, A., Migliozzi, P., Scotto Lavina, L., Strolin, P., Tioukov, V., Okusawa, T., Dore, U., Loverre, P.F., Ludovici, L., Rosa, G., Santacesaria, R., Satta, A., Spada, F.R., Barbuto, E., Bozza, C., Grella, G., Romano, G., Sirignano, C., Sorrentino, S., Sato, Y., Tezuka, I., and The CHORUS Collaboration

Published
2007
Full Text
View/download PDF

38. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry

Author

Sorrentino, S. Sartori, S. Baber, U. Claessen, B.E. Giustino, G. Chandrasekhar, J. Chandiramani, R. Cohen, D.J. Henry, T.D. Guedeney, P. Ariti, C. Dangas, G. Gibson, C.M. Krucoff, M.W. Moliterno, D.J. Colombo, A. Vogel, B. Chieffo, A. Kini, A.S. Witzenbichler, B. Weisz, G. Steg, P.G. Pocock, S. Urban, P. Mehran, R.

Subjects
animal structures
Abstract

Background: Whether the underlying risk of bleeding influences the associations between patterns of dual antiplatelet therapy (DAPT) cessation and adverse events after percutaneous coronary intervention is unknown. Methods: Patients enrolled in the prospective, international, multicenter PARIS registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) were categorized according to their risk of bleeding using the PARIS bleeding risk score. We evaluated the incidence, patterns, and association between modes of DAPT cessation and outcomes across bleeding risk groups. Modes of DAPT cessations were defined as physician-guided DAPT discontinuation, brief interruption (

Published
2020

41. Reciprocal modulation of Linc-223 and its ligand miR-125a on the basis of platelet function level

Author

De Rosa, S, primary, La Bella, S, additional, Canino, G, additional, Siller-Matula, J, additional, Eyleten, C, additional, Postula, M, additional, Tamme, L, additional, Iaconetti, C, additional, Sabatino, J, additional, Polimeni, A, additional, Sorrentino, S, additional, Gareri, C, additional, Proto, L, additional, Strangio, A, additional, and Indolfi, C, additional

Published
2020
Full Text
View/download PDF

42. Early aspirin discontinuation following acute coronary syndrome or percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Author

Guedeney, P, primary, Mesnier, J, additional, Sorrentino, S, additional, Abcha, F, additional, Zeitouni, M, additional, Lattuca, B, additional, Silvain, J, additional, De Rosa, S, additional, Indolfi, C, additional, Collet, J.P, additional, Kerneis, M, additional, and Montalescot, G, additional

Published
2020
Full Text
View/download PDF

48. P1966Impact of coronary artery calcification on long-term outcomes after implantation of first and second-generation drug-eluting stents: a patient-level analysis of 18 randomized trials

Author

Guedeney, P, primary, Claessen, B, additional, Mehran, R, additional, Mintz, G, additional, Liu, M, additional, Sorrentino, S, additional, Farhan, S, additional, Leon, M B, additional, Serruys, P, additional, Smits, P C, additional, Von Birgelen, C, additional, Redfors, B, additional, Madhavan, M V, additional, Ben-Yehuda, O, additional, and Stone, G W, additional

Published
2019
Full Text
View/download PDF

49. P5367Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials

Author

Guedeney, P, primary, Sorrentino, S, additional, Giustino, G, additional, Chapelle, C, additional, Claessen, B, additional, Ollier, E, additional, Laporte, S, additional, Camaj, A, additional, Kalkman, D N, additional, Vogel, B, additional, De Rosa, S, additional, Indolfi, C, additional, Collet, J P, additional, Mehran, R, additional, and Montalescot, G, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results